Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis

被引：0
|
作者：
Finckh, Axel [1 ]
Dudler, Jean [2 ]
Wennelinger, Felix [3 ]
Ciurca, Adrian [4 ]
Gabay, Cem [1 ]
Bas, Sylvette [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Univ Lausanne Hosp, Lausanne, Switzerland
[3] Univ Hosp Bern, CH-3010 Bern, Switzerland
[4] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S777 / S777
页数：1
相关论文
共 50 条
  • [1] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [2] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [3] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [4] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [5] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [6] Therapeutic drug monitoring of infliximab biosimilar and anti-infliximab antibodies in inflammatory diseases
    Elberdin, Laida
    Outeda, Maria
    Mateos, Maria
    Martinez, Cristina
    Salvador, Pilar
    Angeles Porta, Maria
    Isabel Martin, Maria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 338 - 339
  • [7] Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
    Casteele, N. Vande
    Buurman, D. J.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    Rispens, T.
    van der Kleij, D.
    Gils, A.
    Dijkstra, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 765 - 771
  • [8] Can Measurements of Anti-Infliximab Antibodies Predict Acute Severe Infusion Reactions to Infliximab?
    Steenholdt, Casper
    Svenson, Morten
    Bendtzen, Klaus
    Thomsen, Ole
    Brynskov, Jorn
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2011, 140 (05) : S774 - S774
  • [9] Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response
    Haraoui, B
    Cameron, L
    Ouellet, M
    White, B
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 31 - 36
  • [10] A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
    van den Bemt, B. J. F.
    Vos, K.
    den Broeder, A. A.
    Blom, M.
    Thurlings, R. M.
    Bartelds, G. M.
    Stapel, S. O.
    Barrera, P.
    Tak, P. P.
    Nurmohamed, M. T.
    Wolbink, G-J
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1368 - 1369
12345